COC(=O)c1ccc2nc3c(cc2c1)[C@@H]1CCN2C(=O)CCC[C@H](C3)[C@H]12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?